Stoke Therapeutics, Inc.

NasdaqGS:STOK Stock Report

Mkt Cap: US$409.3m

Stoke Therapeutics Company Information

Stoke Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Stoke Therapeutics, Inc.
  • Ticker: STOK
  • Exchange: NasdaqGS
  • Founded: 2014
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$409.291m
  • Shares outstanding: 39.43m
  • Website:

Number of Employees


  • Stoke Therapeutics, Inc.
  • 45 Wiggins Avenue
  • Bedford
  • Massachusetts
  • 1730
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
STOKNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDJun 2019
0GTDB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/13 00:00
End of Day Share Price2023/01/12 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.